A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants

NCT05894928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LOXO-783
DRUG: Cholestyramine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]